We are live on
!
Find out more
DB
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter
Est. Return
+6.35%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$25.5B
AUM Growth
+$1.27B
(+5.2%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
11.03%
Holding
2,244
New
814
Increased
508
Reduced
495
Closed
411
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$371M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
US Bancorp
USB
|
+$163M |
| 4 |
Lowe's Companies
LOW
|
+$162M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$249M |
| 2 |
Goldman Sachs
GS
|
+$228M |
| 3 |
Alibaba
BABA
|
+$162M |
| 4 |
Cemex
CX
|
+$157M |
| 5 |
Halliburton
HAL
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.11% |
| 2 | Consumer Discretionary | 12.23% |
| 3 | Healthcare | 10.85% |
| 4 | Technology | 7.76% |
| 5 | Real Estate | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPH
226
DELISTED
Tri Pointe Homes
TPH
| $31.6M | 0.12% |
2,287,622
+2,237,022
| +4,421% | +$29.7M |
|
227
Schneider National
SNDR
$6.28B
| $31.5M | 0.12% |
1,246,431
+34,331
| +3% | +$763K |
|
|
GES
228
DELISTED
Guess Inc
GES
| $31.4M | 0.12% |
+1,843,037
| New | +$26.1M |
|
|
XOG
229
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $31.2M | 0.12% |
2,029,528
+425,324
| +27% | +$5.46M |
|
|
VMW
230
DELISTED
VMware, Inc
VMW
| $31.1M | 0.12% |
284,375
-520,122
| -65% | -$51.4M |
|
231
EQT Corp
EQT
$33.6B
| $30.6M | 0.12% |
860,849
-51,126
| -6% | -$1.74M |
|
232
Invesco Mortgage Capital
IVR
$809M
| $29.9M | 0.12% |
174,362
-3,295
| -2% | -$556K |
|
233
VF Corp
VFC
$5.65B
| $29.7M | 0.12% |
+495,634
| New | +$28.6M |
|
|
ATH
234
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $29.7M | 0.12% |
550,773
-43,654
| -7% | -$2.26M |
|
235
CALL
iShares Russell 2000 ETF
IWM
$81.9B
| $29.6M | 0.12% |
+200,000
| New | +$28.1M |
|
236
Sunstone Hotel Investors
SHO
$2.1B
| $29.6M | 0.12% |
1,839,447
+1,656,808
| +907% | +$26.3M |
|
237
Post Holdings
POST
$3.65B
| $29.4M | 0.12% |
509,328
-162,468
| -24% | -$8.9M |
|
238
Vertex Pharmaceuticals
VRTX
$139B
| $29.1M | 0.11% |
191,630
-200,462
| -51% | -$30.2M |
|
239
Teva Pharmaceuticals
TEVA
$43.5B
| $29M | 0.11% |
+1,645,926
| New | +$37M |
|
240
CBRE Group
CBRE
$44B
| $28.9M | 0.11% |
762,274
+661,011
| +653% | +$24.3M |
|
241
American Tower
AMT
$81.9B
| $28.8M | 0.11% |
210,966
+99,921
| +90% | +$13.9M |
|
242
Boston Scientific
BSX
$73B
| $28.6M | 0.11% |
981,924
-917,642
| -48% | -$25.3M |
|
243
Microchip Technology
MCHP
$41.3B
| $28.4M | 0.11% |
633,476
-1,606,938
| -72% | -$67.4M |
|
|
WBT
244
DELISTED
Welbilt, Inc.
WBT
| $28.4M | 0.11% |
1,230,997
+1,219,867
| +10,960% | +$24.7M |
|
|
CLVS
245
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $28.3M | 0.11% |
344,000
+179,000
| +108% | +$14.2M |
|
|
RPAI
246
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $28.3M | 0.11% |
2,158,727
+664,736
| +44% | +$8.7M |
|
247
M&T Bank
MTB
$34.7B
| $28.3M | 0.11% |
+175,846
| New | +$27.6M |
|
248
Encompass Health
EHC
$11.9B
| $28M | 0.11% |
760,029
-17,188
| -2% | -$612K |
|
249
Take-Two Interactive
TTWO
$44.8B
| $27.9M | 0.11% |
273,014
+135,516
| +99% | +$12.1M |
|
|
PDCE
250
DELISTED
PDC Energy, Inc.
PDCE
| $27.8M | 0.11% |
567,055
-269,970
| -32% | -$11.6M |
|
Similar funds
CBU
Dmitry Balyasny's Q3 2017 Portfolio in Review
As of Q3 2017, Dmitry Balyasny held 2,244 positions worth $25.5B, up 5.2% from $24.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny's Q3 2017 filing shows 814 new, 508 increased, 495 reduced and 411 closed positions. Its largest new stake was Range Resources: 5,316,064 shares worth $104M. The largest sale was Bank of America, an estimated $249M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q3 2017 buy was Range Resources: 5,316,064 shares worth $104M.
- Dmitry Balyasny added most to JPMorgan Chase in Q3 2017, an estimated $371M increase.
- Dmitry Balyasny's biggest Q3 2017 reduction was Bank of America, cutting an estimated $249M.
- Dmitry Balyasny fully exited Cemex in Q3 2017, selling an estimated $157M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $25.5B portfolio in Q3 2017.
- Dmitry Balyasny opened 814 new positions and closed 411 in Q3 2017.
- Dmitry Balyasny's portfolio value rose 5.2% quarter-over-quarter to $25.5B.
Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.